Skip to content
Screener

AOCI at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$2.5B-6.6%
Danaher logo
DanaherDHR
-$795M-39.7%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$363.2M+7.4%
WAT
Waters CorporationWAT
-$168M-12.1%
Agilent Technologies logo
Agilent TechnologiesA
-$202M+27.9%
Illumina logo
IlluminaILMN
$1M-87.5%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemApril 5,2026December 28,2025
Stockholders’ equity:
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 111,629,000 shares and 112,281,000 shares at April 5, 2026 and December 28, 2025, respectively111,629112,281
Capital in excess of par value1,237,4441,305,900
Retained earnings6,087,2226,054,314
Accumulated other comprehensive loss(253,556)(222,135)
Total stockholders’ equity7,182,7397,250,360
Total liabilities and stockholders’ equity$11,996,590$12,168,411

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's AOCI?
Revvity (RVTY) reported AOCI of -$253.56M in Q1 2026.
How has Revvity's AOCI changed year-over-year?
Revvity's AOCI increased by 19.9% year-over-year, from -$316.45M to -$253.56M.
What is the long-term trend for Revvity's AOCI?
Over 5 years (2020 to 2025), Revvity's AOCI has grown at a 47.4% compound annual growth rate (CAGR), from -$31.96M to -$222.14M.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Ask your AI about Revvity's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude